NovoCure Ltd. (NVCR) PT Lowered to $42 at Wells Fargo

Go back to NovoCure Ltd. (NVCR) PT Lowered to $42 at Wells Fargo

Novocure to Report First Quarter 2024 Financial Results

April 1, 2024 7:00 AM EDT

ROOT, Switzerland--(BUSINESS WIRE)-- Novocure (NASDAQ: NVCR) announced today that it will report financial results for the first quarter 2024 on Thursday, May 2, 2024, before the U.S. financial markets open. Novocure management will host a conference call and webcast to discuss the companys financial results for the three months ended March 31, 2024, at 8:00 a.m. EDT on Thursday, May 2, 2024. To access the conference call by phone, use the following... More